All companies › AORT

AORT · ARTIVION, INC.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells4
Research cases0
Last filing2026-09-10

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-19 — Mackin James P · sold 70,000 @ $28.96 2026-09-02 — GREEN ANDREW M · sold 6,510 @ $27.27 2026-09-03 — GREEN ANDREW M · sold 1,493 @ $26.02 2026-09-10 — GREEN ANDREW M · sold 11,480 @ $24.97
2026-08-192026-09-10

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

GREEN ANDREW M SVP, Regulatory and Quality
Mackin James P President & CEO
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $AORT is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-10', 'insider_name': 'GREEN ANDREW M', 'insider_title': 'SVP, Regulatory and Quality', 'transaction_type': 'Open-market sell', 'shares': 11480.0, 'price': 24.97, 'value': 286655.6, 'is_buy': False}, {'transaction_date': '2026-09-03', 'insider_name': 'GREEN ANDREW M', 'insider_title': 'SVP, Regulatory and Quality', 'transaction_type': 'Open-market sell', 'shares': 1493.0, 'price': 26.02, 'value': 38847.86, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'GREEN ANDREW M', 'insider_title': 'SVP, Regulatory and Quality', 'transaction_type': 'Open-market sell', 'shares': 6510.0, 'price': 27.27, 'value': 177527.7, 'is_buy': False}, {'transaction_date': '2026-08-19', 'insider_name': 'Mackin James P', 'insider_title': 'President & CEO', 'transaction_type': 'Open-market sell', 'shares': 70000.0, 'price': 28.96, 'value': 2027200.0, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for AORT today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.